Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of>
37.7 million individuals globally. HF is a shared chronic phase of cardiac functional …

Background Atrial fibrillation (AF) and heart failure frequently coexist, commonly resulting in
serious adverse events. With both conditions increasing in prevalence and justified …

5.2. 1. Ocena funkcji skurczowej lewej komory...................................... 1052 5.2. 2. Ocena
funkcji rozkurczowej lewej komory...................................... 1052 5.2. 3. Ocena funkcji prawej …

Aims While mineralocorticoid receptor antagonists (MRAs) have been shown to benefit
patients with reduced left ventricular ejection fraction (LVEF), spironolactone did not reduce …

ST2 is a member of the interleukin-1 receptor family biomarker and circulating soluble ST2
concentrations are believed to reflect cardiovascular stress and fibrosis. Recent studies …

Abstract Stowarzyszenia ESC: Acute Cardiovascular Care Association (ACCA), European
Association for Cardiovascular Prevention and Rehabilitation (EACPR), European …

Background Globally, heart failure (HF) has been recognized as one of the major
cardiovascular disorder with high morbidity, mortality and considerable social impact. In Sub …

Echocardiography, given its safety, easy availability, and the ability to permit a
comprehensive assessment of cardiac structure and function, is an indispensable tool in the …

Background Heart failure with preserved ejection fraction (HFpEF) represents a major global
and economic burden, but its epidemiological, clinical, and outcome data have varied …

Background Hospitalizations for heart failure with preserved ejection fraction (HFpEF) are
increasing. There are limited data examining national trends in patients hospitalized with …